Study findings show that the standardized 6-month surveillance protocols for all patients with low-risk uveal melanoma may be ...

Until recently, uveal melanoma was a disease that was poorly ... In some people, there may be no symptoms, but it can be picked up by routine eye tests. Some experience issues with their vision ...

One of the biggest challenges with eye cancer is that its symptoms can be subtle or even invisible at first. Regular eye ...

Uveal melanoma is the most common primary malignancy of the eye and frequently leads to metastatic death. Until the mid-20th Century, the only treatment for uveal melanoma was enucleation.

"Sun exposure causes damage to the cells in your skin and causes abnormal growth of melanocytes, which is a type of skin cell ...

Uveal melanoma is the most common primary malignancy of the eye in adults and affects approximately four people per million in the USA each year. Historically, patients were treated with ...

This disease, known as metastatic uveal melanoma, is traditionally very hard to treat and usually has poor outcomes. The phase 3 FOCUS trial, published in the Annals of Surgical Oncology ...

IDE196 has been granted Breakthrough Therapy designation for neoadjuvant treatment of primary uveal melanoma, highlighting its potential in addressing unmet medical needs. The FDA's Breakthrough ...